Prostate cancer

Prostate cancer

Reveals the risk of prostate cancer

Genetic analysis that can confirm or exclude a high risk of prostate cancer, which is one of the most frequently diagnosed cancers in men in the Czech Republic. Nearly eight thousand new cases are diagnosed annually. It is a cancer for which hereditary predispositions are a significant risk factor. Some of these cancers are caused by inherited cancer predispositions in risk genes. The result of the analysis will give you an answer as to whether you are at increased risk of developing this disease and, if necessary, allow you to take the necessary measures in time. 

Prostate cancer
20 000 Kč
WHEN DO I RECEIVE THE RESULT?

WHEN DO I RECEIVE THE RESULT?

In 3-6 months after receiving your sample.

More info
HOW THE SAMPLE IS TAKEN

HOW THE SAMPLE IS TAKEN

By oral swab or blood collection.

More info
FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS

An overview of your most frequently asked questions and our answers.

More info

IN WHICH SITUATIONS IT IS APPROPRIATE TO TAKE THE TEST

PUBLIC HEALTH INSURANCE COVERS THE TEST IN THE FOLLOWING SITUATIONS

When testing for prostate cancer is covered by public health insurance:

Testing indications for prostate cancer: 

  • Incidence of ≥ 2 cases of prostate cancer in personal or family history, with at least one at age ≤ 55 years.
  • ≥ 3 cases of prostate cancer in close relatives, death due to prostate cancer. 
  • Prostate cancer (Gleason score ≥ 7) or primary metastatic prostate cancer and ≥ 1 case of breast cancer, ovarian cancer, endometrial cancer, bowel or stomach cancer, renal cell carcinoma, malignant melanoma, pancreatic cancer, bladder cancer, gallbladder cancer. 

If the relative who was diagnosed with cancer is no longer living, testing according to the above criteria is possible for first-degree relatives, with a family history on the mother's side for second-degree ones.

If you have a personal and/or family history of other cancers (colon or small bowel cancer, uterine cancer, kidney cancer, etc.), the genetic analysis may also be covered by public health insurance after a risk assessment by a clinical geneticist.

Schedule a genetic consultation.

IF YOU MEET ANY OF THESE INDICATIONS, PLEASE CONTACT US AT
strong>800 390 390

DETAILED INFORMATION

DETAILED INFORMATION

Compared to patients without genetic predisposition, hereditary prostate cancer is often diagnosed at a younger age, the disease course may be more aggressive and the survival time shorter. People of reproductive age with a proven gene mutation can be offered preimplantation diagnosis as part of the IVF and prevent transmission of the risk disposition to the next generation by selecting a suitable embryo.

Men with a mutation in the BRCA2 gene have up to a 20% higher lifetime risk of prostate cancer. Targeted prevention of this disease is therefore very important, as prostate tumours grow slowly and with early diagnosis there is a good chance of a complete cure. 

Genetic analysis examines mutations in the BRCA1, BRCA2, CHEK2, HOXB13, ATM genes. In case of a positive finding, genetic consultation and predictive testing of the patient's blood relatives is recommended. 

You will receive the result in 3-6 months.
HOW THE TEST WORKS AND WHAT YOU CAN EXPECT

HOW THE TEST WORKS AND WHAT YOU CAN EXPECT

After ordering the test, you will receive an email with detailed information. A DNA sample is most often obtained through an oral swab or blood sample. You can perform the oral swab yourself in the comfort of your own home using a collection kit, which will be sent to you by mail together with instructions and other documents. You can have your blood drawn at your local physician's office or at our outpatient clinic. The result of the analysis will be sent to you by e-mail or by post as agreed. In case of a positive result, we will arrange a consultation with a clinical geneticist who will explain everything and recommend appropriate measures.

Frequently Asked Questions

The time required for the laboratory examination (sample analysis) and the delivery date of the result vary according to the type and complexity of the examination. Usually it is in the order of weeks, for complex tests up to several months. The delivery date of the result is indicated in the details of each test on our website. In urgent situations, e.g. for a woman with a newly diagnosed breast or ovarian tumour before surgery, the oncopanel cancer test is performed in STATIM mode and the result is available within 3-4 weeks, whereas in normal mode it takes up to 6 months.
Health insurance always covers genetic consultations recommended by the attending physician (usually a general practitioner, paediatrician, oncologist, gynaecologist or other specialist). During the consultation, a clinical geneticist will assess whether the indication criteria for testing for the predisposition genes are met; if so, the entire genetic test, including laboratory analysis of the sample and subsequent consultation with the geneticist/doctor, is covered by health insurance. If the criteria for the genetic testing are not met, the patient can pay for the selected/recommended test as a self-payment.
After making an appointment, you will come to our office where you will first fill out a personal and family history questionnaire, or you can download it from here on our website and fill it out in advance, in the comfort of your own home. Remember to bring it with you afterwards. This is followed by a consultation with a doctor who will compile your three-generation family tree and decide on the indication for laboratory genetic testing. We also recommend that you bring medical reports from recent important examinations.
Recommendation - a referral from the doctor who recommended the genetic consultation. Alternatively, a completed genetic family and personal history questionnaire, which can be downloaded here. However, the questionnaire can also be completed after you arrive at our office. Medical reports from previous examinations related to the requested genetic test. It is not necessary to be fasting for the genetic examination, so you can easily make an appointment in the afternoon.
It has been reported that approximately 5-10% of cancers are caused by inborn changes in certain genes. One of the main goals of predictive genetic testing is the early identification of people at risk. If risk predispositions (gene mutations) are detected, preventive follow-up at specialised centres is recommended, where possible cancers are detected early and the chances of successful treatment are increased. In the case of high-risk mutations, preventive surgery may be recommended to make the risk of cancer in a given organ virtually impossible (for example, removal of the breast glands or removal of the uterus and ovary in BRCA1 or BRCA2 mutation carriers).
If your first-degree relative (parents, siblings, children) develops colon cancer before the age of 45, your risk of developing this cancer is 5 times higher. If you have three first-degree relatives, your risk can be as high as 50%. In families with a history of recurrent bowel cancer or with a history of bowel cancer at a young age, it could be hereditary cancer syndrome (Lynch syndrome). In such cases, genetic consultation is recommended.

Do you have a question or don't know which test to choose?

Call us at 800 390 390 or contact us and we'll be happy to help.